Atopic Dermatitis Market – 2018-2028 – with Focus on 21 Major Markets – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Epiomic
Epidemiology Series: Atopic Dermatitis Forecast In 21 Major Markets
2018-2028”
report has been added to ResearchAndMarkets.com’s
offering.

This report provides the current prevalent population for Atopic
Dermatitis across 21 Major Markets (USA, Canada, France, Germany, Italy,
Spain, UK, Poland, Netherlands, Russia, Turkey, South Africa, Japan,
China, South Korea, Singapore, India, Australia, Brazil, Mexico,
Argentina) split by gender and 5-year age cohort. Along with the current
prevalence, the report provides an overview of severity, location and
IgE levels of Atopic Dermatitis, to name a few. The report also contains
a disease overview of the risk factors, disease diagnosis and prognosis
along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team, several
of the main symptoms and co-morbidities of Atopic Dermatitis have been
quantified and presented alongside the overall prevalence figures. These
sub-populations within the main disease are also included at a country
level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Atopic Dermatitis include:

  • Asthma
  • Rhinitis
  • Allergies (Food- or Inhalant-related)
  • Rashes
  • Eczemic lesions

Reasons to buy

  • Able to quantify patient populations in global Atopic Dermatitis
    market to target the development of future products, pricing
    strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of
    Atopic Dermatitis and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study
    sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid
    conditions on Atopic Dermatitis prevalent population.
  • Identify sub-populations within Atopic Dermatitis which require
    treatment.
  • Gain an understanding of the specific markets that have the largest
    number of Atopic Dermatitis patients.

Key Topics Covered:

  • Introduction
  • Cause of the Disease
  • Risk Factors & Prevention
  • Diagnosis of the Disease
  • Variation by Geography/Ethnicity
  • Disease Prognosis & Clinical Course
  • Key Comorbid Conditions/Features Associated with the Disease
  • Methodology for Quantification of Patient Numbers
  • Top-Line Prevalence for Atopic Dermatitis
  • Features of Atopic Dermatitis Patients
  • Abbreviations used in the Report
  • Other Services & Solutions
  • Reports & Publications
  • Online Epidemiology Databases
  • Online Pharmaceutical Pricing Database
  • References
  • Appendix

For more information about this report visit https://www.researchandmarkets.com/research/tqpsdp/atopic_dermatitis?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Dermatological
Drugs